Amedeo Smart

Free Medical Literature Service

 

Amedeo

Obstructive Lung Diseases
  Free Subscription

Articles published in
Respir Med
    February 2026
  1. DA SILVA CRV, Costa EC, Sarinho E, Correia Junior MGA, et al
    Anxiety is associated with asthma severity in adolescents: a school-based epidemiological study.
    Respir Med. 2026 Feb 25:108731. doi: 10.1016/j.rmed.2026.108731.
    >> Share

  2. TANAKA Y, Okamura K, Kaburaki S, Tanaka T, et al
    Utility of MostGraph in Asthma Management: Comparative Study with Cough-Variant Asthma.
    Respir Med. 2026 Feb 24:108728. doi: 10.1016/j.rmed.2026.108728.
    >> Share

  3. AL-IEDE M, Al-Zayadneh E, Fallouh J, Al-Huneidy R, et al
    Temporal trends and projections of asthma in North Africa and Middle East: insights from Global Burden of Disease 2023.
    Respir Med. 2026 Feb 23:108727. doi: 10.1016/j.rmed.2026.108727.
    >> Share

  4. SUMINO K, D'Souza A, Tapp H, Francisco B, et al
    Development and feasibility of provider implementation tools for anti-inflammatory reliever therapy in community asthma practices.
    Respir Med. 2026;254:108717.
    >> Share

  5. KAPATAIS C, Papaioannou AI, Fouka E, Samitas K, et al
    Optimizing adherence to inhaled therapy in asthma: Behavioral and digital strategies with insights from the Greek healthcare context.
    Respir Med. 2026 Feb 10:108709. doi: 10.1016/j.rmed.2026.108709.
    >> Share

  6. LUO W, Yu Z, Zhang Y, Lin D, et al
    The C-Reactive Protein-Albumin-Lymphocyte (CALLY) index and all-cause mortality in adults with Asthma: A cohort study using NHANES 1999-2010.
    Respir Med. 2026;253:108706.
    >> Share

  7. PEDROSO A, Oliveira JM, Clark VL, McLoughlin RF, et al
    Obesity and impaired muscle function in severe asthma: a cross sectional study.
    Respir Med. 2026 Feb 4:108698. doi: 10.1016/j.rmed.2026.108698.
    >> Share

  8. CRISTOPOULOU ME, Panteli LS, Moisidis JAlpha, Christopoulos I IA, et al
    The bacterial lysate OM-85 Reduces Exacerbations and Oral Corticosteroid Use in Frequently Exacerbating Patients with T2-High Asthma: The OMREXA Real-World Evidence Study.
    Respir Med. 2026 Feb 4:108695. doi: 10.1016/j.rmed.2026.108695.
    >> Share

  9. HAN J, Yan Y, Du Z, Huang H, et al
    Genetically Predicted Associations Between Blood Cell Perturbation Responses and Bronchiectasis Through Immune Mediation: A Mendelian Randomization Study.
    Respir Med. 2026 Feb 3:108701. doi: 10.1016/j.rmed.2026.108701.
    >> Share

  10. ZHANG X, Xie S, Cao X, Liu Q, et al
    Evaluation of an air quality Alert-Based intervention in patients with stable chronic obstructive pulmonary Disease: A prospective randomized controlled trial.
    Respir Med. 2026;252:108668.
    >> Share

  11. ZHOU C, Liu J, Yi Q, Zeng J, et al
    PA/A ratio >1 detected by CT-scan during acute exacerbation of chronic obstructive pulmonary disease: A novel prognostic factor for long-term mortality based on a cohort study.
    Respir Med. 2026;252:108665.
    >> Share

  12. KAZDA L, Schlub TE, Guppy M, Forrester M, et al
    Impact of carbon footprint information on inhaler prescribing intentions by general practitioners: protocol for an online factorial randomised experiment.
    Respir Med. 2026;252:108657.
    >> Share

  13. TSUJI H, Mitsuya S, Tsuruoka K, Nakamura T, et al
    A novel respiratory reactance index, frequency-dependent, and for effort-independent assessment of COPD severity using MostGraph.
    Respir Med. 2026;252:108656.
    >> Share

  14. JONES PW, Hu X, Dong F, Huang K, et al
    A prospective study of maintenance treatment for COPD patients hospitalised for severe exacerbations.
    Respir Med. 2026;252:108648.
    >> Share

  15. FORTIS S, Comellas AP, Bowler RP, Bhatt SP, et al
    Relationships between bronchodilator responsiveness, a COPD polygenic risk score, and COPD progression.
    Respir Med. 2026;252:108636.
    >> Share

  16. MANISCALCO M, Candia C, Pennisi F, Pennisi A, et al
    Clinical stability under FF/UMEC/VI triple inhaled therapy: A 12-month real life retrospective observational study.
    Respir Med. 2026;252:108633.
    >> Share

  17. YAN Y, Jiang J, Xiang L, Zhang J, et al
    Clinical value of vascular endothelial glycocalyx in acute exacerbation of chronic obstructive pulmonary disease.
    Respir Med. 2026;252:108622.
    >> Share

  18. ABOU-RJEILI M, Farias R, Mostafavi Y, Smith B, et al
    Personalizing the approach for the diagnosis of patients with concomitant Chronic Obstructive Pulmonary Disease and Heart failure.
    Respir Med. 2026;252:108628.
    >> Share

  19. MCDONALD VM, Blickisdorf T, de Oliveira JM, Scott HA, et al
    Managing obesity as a treatable trait of obstructive airway diseases.
    Respir Med. 2026;252:108606.
    >> Share

    January 2026
  20. JESENAK M, Diamant Z, Conti D, Antolin-Amerigo D, et al
    Corrigendum to "The EUFOREA pocket guide on paediatric asthma: A step forward in patient care" [Respir. Med. (2025) 108631].
    Respir Med. 2026 Jan 31:108692. doi: 10.1016/j.rmed.2026.108692.
    >> Share

  21. CUNILL V, Andreu V, Iglesias A, Berman M, et al
    Profiles of circulating T follicular helper (cTfh) cell subpopulations in patients with asthma, COPD and asthma-COPD overlap (ACO).
    Respir Med. 2026;253:108672.
    >> Share

  22. ONO K, Ito M, Harada R, Ohe T, et al
    Prognosis of patients with bronchiectasis receiving long-term oxygen therapy.
    Respir Med. 2026;252:108655.
    >> Share

  23. MANISCALCO M, Candia C, Ambrosino P, Matera MG, et al
    Fractional Exhaled Nitric Oxide in Monitoring Biological Treatment for Severe Asthma in Adults: Clinical Implications and Future Perspectives.
    Respir Med. 2026 Jan 12:108647. doi: 10.1016/j.rmed.2026.108647.
    >> Share

  24. JESENAK M, Diamant Z, Conti D, Antolin-Amerigo D, et al
    The EUFOREA pocket guide on paediatric asthma: A step forward in patient care.
    Respir Med. 2026 Jan 6:108631. doi: 10.1016/j.rmed.2025.108631.
    >> Share

  25. JANSON C, Malinovschi A, Borres M, Faner R, et al
    Allergic sensitization in asthma and COPD in the NOVELTY study.
    Respir Med. 2026;251:108605.
    >> Share

  26. CARVALHAL G, Diniz JM, Hespanhol LC, Barbosa Izoton Cabral DC, et al
    Exacerbation risk in patients with bronchiectasis receiving DPP-1 inhibitors vs placebo: A meta-analysis of RCTs.
    Respir Med. 2026;251:108607.
    >> Share

  27. DOMAGALA-MANCZYK I, Miszczuk-Ciesla M, Maskey-Warzechowska M, Zielecki M, et al
    Limitation of the effectiveness of inhalation training in patients with asthma and COPD.
    Respir Med. 2026;251:108603.
    >> Share

  28. BARISIONE G, Stanojevic S, Brusasco V
    Zone of z-scores uncertainty in pulmonary function interpretation: A proof-of-concept study from CO and NO lung diffusing capacities.
    Respir Med. 2026;251:108600.
    >> Share

  29. LAU CE, van der Burg NMD, Ankerst J, Bjermer L, et al
    ADAM17 and related epithelial injury markers in bronchoalveolar lavage and blood distinguish COPD from controls.
    Respir Med. 2026;251:108596.
    >> Share

  30. MARRADES P, De Angelis A, Iorfida A, Perea L, et al
    Bronchiectasis and treatable traits: the journey from concept to clinical practice.
    Respir Med. 2026;251:108593.
    >> Share

  31. ROHDE G, Vogelmeier CF, Beeh KM, Kardos P, et al
    TETRIS - Prospective study to observe clinical outcomes of triple therapy in COPD patients: Up to 12 months interim analysis.
    Respir Med. 2026;251:108597.
    >> Share

  32. MORIKAWA Y, Morimoto K, Kodani T, Miyahara Y, et al
    Safety and efficacy of a helium-oxygen mix for pediatric respiratory failure associated with anatomical and functional stenotic lesions of the airway: a phase II clinical trial.
    Respir Med. 2026;251:108592.
    >> Share

  33. JIANG D, Wang M
    Reciprocal association between chronic obstructive pulmonary disease and gastrointestinal diseases: A prospective cohort study.
    Respir Med. 2026;251:108589.
    >> Share

  34. WU Z, Wang D, Tang C
    Comorbid management of chronic obstructive pulmonary disease and heart failure.
    Respir Med. 2026;251:108575.
    >> Share

  35. BREA TP, Sanz CZ, Lado-Baleato O, Gude F, et al
    Prognostic influence of cardiac comorbidities in chronic obstructive pulmonary disease.
    Respir Med. 2026;251:108544.
    >> Share

  36. DULAI V, Keglevich A, Santa B, Abonyi-Toth Z, et al
    Real-world efficacy of BDP/FF/G fixed triple inhalation powder (NEXThaler) therapy in the treatment of moderate to severe COPD patients (RESPONSE study).
    Respir Med. 2026;251:108498.
    >> Share

    December 2025
  37. CHEN F, Lu M, Ye J, Zhang L, et al
    Association between fractional exhaled nitric oxide (FeNO) and blood eosinophil count among children and adolescents with asthma in the United States: a population-based study.
    Respir Med. 2025 Dec 31:108630. doi: 10.1016/j.rmed.2025.108630.
    >> Share

  38. CLARK VL, de Oliveira JM, Gibson PG, McDonald VM, et al
    Prevalence and overlap of treatable traits in severe asthma and COPD: A cross-disease comparison in a tertiary care setting.
    Respir Med. 2025;252:108604.
    >> Share

  39. JESENAK M, Bobcakova A, Golebski K, Krohn IK, et al
    Airway epithelial barrier integrity: an emerging treatable trait in asthma management.
    Respir Med. 2025;252:108579.
    >> Share

  40. SUBOCZ J, Stoup T, Giovannelli J, Bourdin A, et al
    Evolution and factors associated with presenteeism in severe asthma after treatment with biologics.
    Respir Med. 2025;251:108587.
    >> Share

  41. SARAVANAKUMAR T, Mohanakrishnan R
    Effects of neuromuscular breathing exercise with yogic practices on cardiopulmonary variables among women asthmatic patients: A randomized controlled trial.
    Respir Med. 2025;251:108583.
    >> Share

  42. LIAN X, Li C, He J, Wu P, et al
    The association between decreased ALPS index and emphysema as well as cognitive function in patients with COPD.
    Respir Med. 2025;251:108571.
    >> Share

  43. DE SANTANA MBR, Cruz AA, de Araujo JLF, Tugores RM, et al
    Variants in the Glucocorticoid Receptor gene (NR3C1), asthma control and serum cytokine levels.
    Respir Med. 2025;251:108553.
    >> Share

  44. CHEN SJ, Kalra A, Muelly M, Reicher J, et al
    Automated artificial intelligence detection of early or under-diagnosed interstitial lung disease by computed tomography in the COPDGene trial.
    Respir Med. 2025;250:108545.
    >> Share

  45. KALUCZA S, Coe AB, Hajdarevic S, Blomberg A, et al
    Associations between self-conscious emotions and sociodemographic factors, lifestyle, burden of disease, and healthcare interventions: A cross-sectional study with people with chronic obstructive pulmonary disease.
    Respir Med. 2025;250:108539.
    >> Share

  46. ALRABBAIE H, Beauchamp M, Ellerton C, Goldstein R, et al
    Determinants of balance impairment in individuals with Chronic Obstructive Pulmonary Disease: A secondary analysis of a randomized controlled trial.
    Respir Med. 2025;250:108537.
    >> Share

  47. YOUK CS, Kim DK, Rhee CK, Choi CW, et al
    Early termination of six-min walk test in COPD as simple prognostic marker vs. BODE index.
    Respir Med. 2025;250:108538.
    >> Share

  48. FRASSANITO A, Nenna R, Petrarca L, Pierangeli A, et al
    Neutrophilic and eosinophilic inflammation in bronchiolitis and long-term respiratory sequelae.
    Respir Med. 2025;250:108521.
    >> Share

  49. PARK WH
    The mitochondrial nexus: Dysfunction, inhibition, and therapeutic frontiers in lung disease.
    Respir Med. 2025;250:108506.
    >> Share

  50. HAMZA YOUSEF MS, Al Azizi HM, Fouad MM
    Point of care ultrasound as a bedside diagnostic tool in acute dyspnea patients in emergency department for timely management.
    Respir Med. 2025;250:108500.
    >> Share

  51. PATEL M, Marshall J, Martinez FJ, Mushunje A, et al
    Frequent productive cough in COPD relates to exacerbation risk and treatment benefit from budesonide/glycopyrrolate/formoterol fumarate: a post hoc analysis of KRONOS.
    Respir Med. 2025;250:108499.
    >> Share

    November 2025
  52. WANG W, Cai H, Fan H, Duan D, et al
    Occurrence of allergic bronchopulmonary aspergillosis in Chinese adults with asthma and COPD comorbidity.
    Respir Med. 2025;251:108547.
    >> Share

  53. SAGAYARAJ MJ, Panneerselvam S, Jeganathan HR, Theivendren P, et al
    Advances in Asthma-COPD Overlap Treatment: A Comprehensive Review of Therapeutic Approaches.
    Respir Med. 2025 Nov 26:108542. doi: 10.1016/j.rmed.2025.108542.
    >> Share

  54. CHOI YM, Womble JT, Greene ST, Vanetta C, et al
    Short-term impact of bariatric surgery on systemic inflammation in patients with asthma.
    Respir Med. 2025;250:108540.
    >> Share

  55. STRIDSMAN C, Konradsen JR, Andersson N, Vanfleteren LEGW, et al
    Extremely-to-very preterm birth and being small for gestational age increase the risk of severe airflow obstruction in patients with asthma.
    Respir Med. 2025;250:108536.
    >> Share

  56. ZHAO L, Chen G, Huang C, Kong W, et al
    Machine learning for prediction of eosinophilic asthma using clinical indicators as an alternative to induced sputum.
    Respir Med. 2025 Nov 19:108528. doi: 10.1016/j.rmed.2025.108528.
    >> Share

  57. CHEN F, Ye J, Zhang L, Lin BQ, et al
    Associations of serum cotinine with asthma risk in US children: a mediation analysis of body mass index.
    Respir Med. 2025 Nov 12:108502. doi: 10.1016/j.rmed.2025.108502.
    >> Share

  58. BARRY LE, Habib M, Heaney LG, Nianogo RA, et al
    Socioeconomic Disparities in Inpatient Outcomes Among US Pediatric Asthma Hospitalizations.
    Respir Med. 2025 Nov 11:108501. doi: 10.1016/j.rmed.2025.108501.
    >> Share

  59. CHEN L, Chen H, Chen Z, Zhang K, et al
    Visceral obesity, partly mediated by a reduction in HDL-C, increases the risk of asthma: Insights from NHANES and Mendelian randomization studies.
    Respir Med. 2025;249:108482.
    >> Share

  60. BERTHON BS, Williams LM, McLoughlin RF, Nichol KS, et al
    Pilot investigation of an oligosaccharide blend in adults with asthma - a double-blind, randomised, placebo-controlled, 4-arm crossover trial.
    Respir Med. 2025 Nov 3:108474. doi: 10.1016/j.rmed.2025.108474.
    >> Share

  61. ZHANG S, Shen K, Sun B, Liu B, et al
    Associations of the prevalence of chronic respiratory diseases and mortality with blood furan levels: a population-based study.
    Respir Med. 2025;248:108422.
    >> Share

  62. HANSEN FR, Pedersen DC, Madsen F, Backman H, et al
    Childhood body size and risk of chronic obstructive pulmonary disease in adulthood: a prospective cohort study.
    Respir Med. 2025;248:108416.
    >> Share

  63. HARRISON SL, Loughran KJ, Suri S, Franklin A, et al
    The continuous daily work of living with chronic obstructive pulmonary disease: An ethnographic study.
    Respir Med. 2025;248:108405.
    >> Share

  64. ZHANG X, Xue J, Chang Y, Zhang R, et al
    Non-pharmacological interventions for fatigue in patients with chronic obstructive pulmonary disease: a systematic review and network meta-analysis.
    Respir Med. 2025;248:108409.
    >> Share

  65. MATERA MG, Page C, Cazzola M
    Sarcopenia as a treatable trait in COPD: From mechanisms to management.
    Respir Med. 2025;248:108401.
    >> Share

  66. BAKAKOS A, Sotiropoulou Z, Anagnostopoulos N, Vontetsianos A, et al
    Anti-inflammatory agents for the management of COPD - Quo Vadis?
    Respir Med. 2025;248:108396.
    >> Share

  67. CHOI JY, Yoon HK, Kim Y, Jang JG, et al
    Comparison of chronic bronchitis definitions in COPD for predicting 10-year all-cause mortality.
    Respir Med. 2025;248:108389.
    >> Share

  68. WANG H, Fan M, Wu J, Liu H, et al
    Development of a questionnaire on supportive care needs of patients with COPD combined with respiratory failure on noninvasive ventilators and evaluating its reliability and validity.
    Respir Med. 2025;248:108384.
    >> Share

  69. KARAKURT G, Demireller M, Ucgun H, Guven O, et al
    EzPAP therapy versus non-invasive ventilation for hypercapnic chronic obstructive pulmonary disease exacerbation: a randomized clinical trial.
    Respir Med. 2025;248:108383.
    >> Share

  70. ALVAREZ-MARTINEZ CJ, Hernandez M, Velez J, Sanchez-Covisa J, et al
    Clinical and economic impact of concomitant heart failure in patients with exacerbated COPD.
    Respir Med. 2025;248:108381.
    >> Share

  71. WU SC, Wu CY, Chien JY, Dong YH, et al
    Predicting response to inhaled corticosteroid maintenance therapy in patients with chronic obstructive pulmonary disease using machine learning models.
    Respir Med. 2025;248:108378.
    >> Share

  72. TSILIGIANNI I, Papageorgakopoulou S, Bouloukaki I
    Adherence to the Chronic Obstructive Pulmonary Disease guidelines in primary care: The Greek COPD COCARE study.
    Respir Med. 2025;248:108345.
    >> Share

  73. NIELSEN LB, Olsson M, Weinreich UM, Ekstrom M, et al
    Associations between chronic airflow limitation, respiratory symptoms, and quality of life across alcohol use categories: a population based study.
    Respir Med. 2025;248:108350.
    >> Share

  74. SUTER P, Greig R, Chan R, Lipworth B, et al
    Efficacy of dupilumab and mepolizumab in eosinophilic COPD: insights from phase 3 trials.
    Respir Med. 2025;248:108343.
    >> Share

  75. BHUTANI M, Mullerova H, Patel D, Barjaktarevic I, et al
    Disease burden and health-related outcomes of patients discharged from hospital following a COPD exacerbation in the United States.
    Respir Med. 2025;248:108337.
    >> Share

  76. CAZZOLA M, Hanania NA, Rogliani P
    Comorbidities as treatable traits of chronic airway diseases.
    Respir Med. 2025;248:108333.
    >> Share

  77. MOUROUVIN-CHEVOLOT E, Laurent L, Claude F, Westeel V, et al
    Distinctive computed tomography features of chronic obstructive pulmonary disease among dairy farmers and smokers.
    Respir Med. 2025;248:108319.
    >> Share

  78. SEPULVEDA-LOYOLA W, Tang C, Alvarez-Bustos A, Cuyul-Vasquez I, et al
    Exploring pulmonary rehabilitation programs implemented and conducted in Latin America for people with chronic respiratory conditions: A scoping review.
    Respir Med. 2025;248:108310.
    >> Share

  79. SANCHEZ FM, Bommatty MS, Haro MQ, Ruiz FO, et al
    Telemonitoring in patients with COPD: A prospective study with results from the AIRE project.
    Respir Med. 2025;248:108307.
    >> Share

  80. HE H, Qiu L, Yang H
    Age-specific profiles and ICU predictors in pediatric plastic bronchitis: A multicenter Chinese cohort study, 2014-2025.
    Respir Med. 2025;249:108473.
    >> Share

  81. GUPTA N, Mohan S, Cattamanchi A, Prasad B, et al
    Effect of eosinophilia on duration of hospital stay in patients admitted with acute exacerbation of chronic obstructive pulmonary disease.
    Respir Med. 2025;249:108467.
    >> Share

  82. YE RH, Wang Z, Ren Z, Mao YJ, et al
    Integrative therapy for lower limb venous thrombosis in patients with COPD: a trial of Rhodiola rosea polyglucoside and pulmonary rehabilitation as a synergistic combination.
    Respir Med. 2025;249:108466.
    >> Share

  83. YE W, Lu W, Yu H, Jia W, et al
    Global burden of young chronic obstructive pulmonary disease in 204 countries and territories from 1990 to 2021: analyses from the global burden of disease study 2021.
    Respir Med. 2025;249:108447.
    >> Share

  84. RANTALA HA, Leivo-Korpela S, Beerling C, Helminen M, et al
    Experienced benefits and side effects affect adherence with long-term noninvasive ventilation.
    Respir Med. 2025;249:108427.
    >> Share

  85. VENKATAPEN D, Caty G, Froidure A, Aboubakar Nana F, et al
    Effect of fan therapy on dyspnea in patients with chronic respiratory diseases during exercise: A randomized controlled trial.
    Respir Med. 2025;249:108426.
    >> Share

  86. AGUSTI A, Gibson P, Cazzola M
    Treatable Traits. Why, What, How?
    Respir Med. 2025;249:108421.
    >> Share

  87. VITACCA M, Riboni G, Paneroni M, Tibollo V, et al
    Timing of cardiovascular events in people with COPD with and without chronic respiratory failure.
    Respir Med. 2025;249:108429.
    >> Share

    October 2025
  88. KOWALCZYK ET, Medubi KM, Meyer MJ, Toriola MA, et al
    Development of novel pegylated imidazobenzodiazepines as inhaled asthma drug candidates.
    Respir Med. 2025 Oct 22:108449. doi: 10.1016/j.rmed.2025.108449.
    >> Share

  89. MACKLE R, Crespo-Gonzalez C, Gray M, Chan M, et al
    Implementing enhanced paediatric asthma care in rural Australia: Qualitative insights from healthcare professionals.
    Respir Med. 2025;249:108444.
    >> Share

  90. DA SILVA LIMA D, Rechenmacher C, Bernardi J, Velleda de Morais R, et al
    SMAD3 gene methylation profile and asthma in childhood: A longitudinal approach.
    Respir Med. 2025;249:108424.
    >> Share

  91. SUTER P, Greig R, Kuo CR, Chan R, et al
    Comparison of oscillometry ratios between IOS and AOS in patients with asthma and COPD.
    Respir Med. 2025 Oct 7:108402. doi: 10.1016/j.rmed.2025.108402.
    >> Share

  92. ARARAT E, Rastogi D, Martin BC
    Metformin use is associated with reduced systemic steroid courses among pediatric asthma patients with diabetes or elevated blood glucose levels.
    Respir Med. 2025 Oct 6:108403. doi: 10.1016/j.rmed.2025.108403.
    >> Share

  93. MURAOKA H, Tsuburai T, Komase Y, Tanaka S, et al
    Association between 6-min walk test and initiation of home oxygen therapy within 3 years in chronic obstructive pulmonary disease managed by primary care physicians.
    Respir Med. 2025;247:108317.
    >> Share

  94. DETTORAKI M, Vandorou KT, Tsoukalas D, Basagianni E, et al
    Ocular manifestations in COPD patients. An underrecognized comorbidity.
    Respir Med. 2025;247:108313.
    >> Share

  95. CAI S, Huang Q, Huang M, Wang J, et al
    Association of aspirin use with mortality in critically ill patients with chronic obstructive pulmonary disease: A retrospective propensity score-matched cohort study.
    Respir Med. 2025;247:108300.
    >> Share

  96. CAZZOLA M, Maniscalco M, Patella V, Calzetta L, et al
    Comparing major COPD triple therapy trials using a structured multi-criteria decision analysis: A deep dive into patient populations and outcomes.
    Respir Med. 2025;247:108292.
    >> Share

  97. CANDIA C, Fuschillo S, Ambrosino P, Motta A, et al
    Exercise-based pulmonary rehabilitation for individuals with chronic obstructive pulmonary disease: What is the potential role of biomarkers? A narrative review.
    Respir Med. 2025;247:108282.
    >> Share

  98. DU BERRY C, Simpson SJ, Spittle AJ, Holland AE, et al
    Exercise training to address lifelong consequences of preterm birth: a survey of perceived needs.
    Respir Med. 2025;247:108284.
    >> Share

  99. NIEDERMAIER T, Alter P, Jorres R, Vogelmeier C, et al
    Parametric estimation of age-, sex-, and spirometry grade-specific mortality in a cohort of COPD patients from Germany: Results from COSYCONET.
    Respir Med. 2025;247:108280.
    >> Share

  100. BECK DA SILVA ETGES AP, Marcolino MAZ, Bianchini L, Kawano-Dourado L, et al
    Economic analysis of high-flow nasal oxygen compared with noninvasive ventilation in patients with acute respiratory failure: results from the RENOVATE randomized clinical trial.
    Respir Med. 2025;247:108270.
    >> Share

  101. VILLAR-AGUILAR L, Casal-Guisande M, Fernandez-Villar A, Garcia-Rodriguez E, et al
    Characterisation of patients with Alpha-1 antitrypsin deficiency using unsupervised machine learning tools.
    Respir Med. 2025;247:108278.
    >> Share

  102. SHAHID H, Ahmed M, Sami SZ, Kumar S, et al
    High-intensity versus low-intensity non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Respir Med. 2025;247:108277.
    >> Share

  103. VERMA B, Kumar N, Ashique S, Debnath B, et al
    Probiotics: An adjuvant treatment strategy for chronic respiratory diseases.
    Respir Med. 2025;247:108268.
    >> Share

  104. EGGLESTON RH, Torghabeh MH, Niven AS, Lim KG, et al
    Bronchodilator Response: Utility and implications in patients undergoing hematopoietic stem cell transplantation.
    Respir Med. 2025;247:108259.
    >> Share

  105. BUENDIA JA, Manrique Acevedo LF, Celis Preciado C
    "Beyond triple Therapy: Is dupilumab a cost-effective option for COPD with type 2 inflammation?".
    Respir Med. 2025;247:108254.
    >> Share

    September 2025
  106. BROZEK G, Nowak B, Prendergast C, Gil A, et al
    Thirty year trends in childhood asthma and allergic conditions in Poland.
    Respir Med. 2025;248:108379.
    >> Share

  107. ALAM ABMN, Gill N, AlAshoor M, Cherif I, et al
    SGLT2-inhibitors and asthma outcomes in type 2 diabetes: Insights from a large multicenter study.
    Respir Med. 2025;248:108357.
    >> Share

  108. FABOZZI A, Bouloukaki I, Bonini M, Schiza SE, et al
    Asthma-OSA overlap syndrome: A distinct endophenotype?
    Respir Med. 2025;248:108344.
    >> Share

  109. HARVEY ES, Hamada Y, Hiles SA, Langton D, et al
    Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry.
    Respir Med. 2025 Sep 3:108340. doi: 10.1016/j.rmed.2025.108340.
    >> Share

  110. DAL NEGRO RW, Turco P, Povero M
    Sensitivity and specificity of various lung function parameters recommended for phenotyping COPD in clinical practice.
    Respir Med. 2025;246:108256.
    >> Share

  111. FERRAZ BD, Faria N, Lacerda C, Mona D, et al
    Spirometry to predict dry powder inhaler performance: Insights from in-check DIAL.
    Respir Med. 2025;246:108249.
    >> Share

  112. BAJPAI J, Kant S, Matera MG, Cazzola M, et al
    Targeting neutrophilic inflammation in obstructive airway disease - A narrative review of brensocatib therapy.
    Respir Med. 2025;246:108243.
    >> Share

  113. WANG JG, Colangelo LA, Meislin R, Khan SS, et al
    Adverse pregnancy outcomes and lung function later in life: The CARDIA lung study.
    Respir Med. 2025;246:108244.
    >> Share

  114. BJORKLUND F, Palm A, Sundh J, Ekstrom M, et al
    A lung function threshold for survival? - FEV(1)Q and mortality in patients with COPD and chronic respiratory failure.
    Respir Med. 2025;246:108242.
    >> Share

  115. BAMONTI PM, Wingood M, Robinson SA, Rose GA, et al
    Psychometric evaluation of the exercise self-regulatory efficacy scale using objective measures of physical functioning in persons with chronic obstructive pulmonary disease.
    Respir Med. 2025;246:108228.
    >> Share

  116. MARQUES A, Antao J, Rodrigues G, Paixao C, et al
    Pulmonary rehabilitation in minimal versus high resource settings in COPD: a non-inferiority and economic evaluation.
    Respir Med. 2025;246:108229.
    >> Share

  117. LI Y, Li X, Li Z, Luo T, et al
    Visceral fat-to-muscle mass ratio to predict cardiovascular events and mortality in patients with chronic obstructive pulmonary disease: A prospective cohort study.
    Respir Med. 2025;246:108215.
    >> Share

  118. HOLM KE, Sandhaus RA, Allison S, Schroth T, et al
    Sleep apnea among individuals with Alpha-1 antitrypsin deficiency-associated lung disease.
    Respir Med. 2025;246:108217.
    >> Share

    August 2025
  119. CELEBI SOZENER Z, Ozdel Ozturk B, Sahinoglu E, Koyluce S, et al
    Benralizumab In Severe Eosinophilic Asthma: A Real-Life Data From Turkiye.
    Respir Med. 2025 Aug 28:108332. doi: 10.1016/j.rmed.2025.108332.
    >> Share

  120. OLIVEIRA JM, Urroz Guerrero PD, Lewthwaite H, Clark VL, et al
    Safety of the 6-minute walk test in adults with severe asthma.
    Respir Med. 2025 Aug 21:108316. doi: 10.1016/j.rmed.2025.108316.
    >> Share

  121. BRIDEVAUX PO, Bourdin A, VAN Ganse E
    Substantial Reduction in Oral Corticosteroid Use After Biologics Initiation in Severe Asthma: An Analysis Based on Swiss Pharmacy Data.
    Respir Med. 2025 Aug 21:108312. doi: 10.1016/j.rmed.2025.108312.
    >> Share

  122. GREIG R, Suter P, Chan R, Lipworth B, et al
    Impact of dupilumab on oscillometry and spirometry derived ratios in severe refractory asthma.
    Respir Med. 2025;247:108315.
    >> Share

  123. CHAN R, Cottini M, Menzella F, Poto R, et al
    Body mass index and lung function decline in persistent asthma.
    Respir Med. 2025 Aug 11:108304. doi: 10.1016/j.rmed.2025.108304.
    >> Share

  124. HOGAARD NV, Sigsgaard T, Agertoft L, Halken S, et al
    Effect of indoor environmental interventions in the home on asthma in children and adolescents: A systematic review.
    Respir Med. 2025 Aug 5:108299. doi: 10.1016/j.rmed.2025.108299.
    >> Share

  125. PATEL C, Sheth V, Koppula R, Kumar A, et al
    Efficacy and safety of novel fixed dose combination of vilanterol, glycopyrronium, and fluticasone furoate dry powder inhaler: A phase 3, randomized, non-inferiority trial compared with fixed dose combination of indacaterol, glycopyrronium, and mometa
    Respir Med. 2025;247:108293.
    >> Share

  126. TU D, Ju S, Xue Y, Xie W, et al
    Association between asthma and advanced cardiovascular-kidney-metabolic syndrome in U.S. adults, a cross-sectional study from NHANES 2011-2023.
    Respir Med. 2025;247:108288.
    >> Share

  127. HSU CC, Tung PH, Lin TY, Huang SW, et al
    Effect of chronic kidney disease on survival in patients with chronic obstructive pulmonary disease.
    Respir Med. 2025;244:108181.
    >> Share

  128. ELLINGSEN J, Janson C, Broms K, Farkhooy A, et al
    Clinical phenotypes predict exacerbations of COPD: the TIE cohort study.
    Respir Med. 2025;244:108182.
    >> Share

  129. HOCHHAUSEN N, Moza A, Kroh A, Rossaint R, et al
    Chronic obstructive pulmonary disease is associated with a higher incidence of acute kidney injury in non-cardiac but not in cardiac surgery ICU-patients: a retrospective MIMIC-III database analysis.
    Respir Med. 2025;244:108160.
    >> Share

  130. QU M, Yang L, Liu K, Tang T, et al
    The effectiveness and feasibility of virtual pulmonary rehabilitation in patients with chronic respiratory diseases: A systematic review and meta-analysis.
    Respir Med. 2025;244:108159.
    >> Share

  131. FAHRENBERG C, Niedermaier T, Alter P, Jorres RA, et al
    Analysis of change in health-related quality of life in patients with COPD over 6 years, including information on dropouts: Results from the German COSYCONET cohort.
    Respir Med. 2025;244:108153.
    >> Share

  132. ZHU B, Xue F, Li M, Chen Y, et al
    Long-term benefits of pulmonary rehabilitation with respiratory muscle training in people with COPD: A retrospective cohort study.
    Respir Med. 2025;245:108214.
    >> Share

  133. GIRI M, Puri A, Chen Y, Liu Y, et al
    Association between Pan-immune-inflammation value and in-hospital mortality in critically ill patients with Chronic obstructive pulmonary disease: An observational study.
    Respir Med. 2025;245:108213.
    >> Share

  134. ZHANG Y, Chen H, Hu S, Chen C, et al
    Construction and validation of a nomogram prediction model for death risk in patients with chronic obstructive pulmonary disease complicated by hypercapnic respiratory failure in the intensive care unit.
    Respir Med. 2025;245:108188.
    >> Share

  135. COLEMAN KM, Varrias D, Wolf E, Schwartz J, et al
    Unrecognized actionable cardiac arrhythmias in patients with moderate to severe chronic obstructive pulmonary Disease: Can continuous monitoring unmask the culprit.
    Respir Med. 2025;245:108190.
    >> Share

  136. HU Y, Hu Y, Dong M, Zheng S, et al
    Integrating clinical phenotypes, impulse oscillometry and fractional exhaled nitric oxide: a robust machine learning model for early asthma prediction in preschool children.
    Respir Med. 2025 Aug 1:108290. doi: 10.1016/j.rmed.2025.108290.
    >> Share

    July 2025
  137. TIRELLI C, Parazzini EM, Sacchi L, Carone G, et al
    Forced Oscillatory Technique R5-19 values correlate with spirometry FEV1/FVC in severe eosinophilic asthma. An observational, prospective, cohort study.
    Respir Med. 2025 Jul 16:108260. doi: 10.1016/j.rmed.2025.108260.
    >> Share

  138. PARK HJ, Lee CH, Lee JK, Kim DK, et al
    Radiologic emphysema predicts accelerated lung function decline in patients with asthma.
    Respir Med. 2025;247:108261.
    >> Share

  139. TIAN C, Xiong S, Song X, Li S, et al
    Spirometry and impulse oscillometry in the diagnosis of cough variant asthma in children.
    Respir Med. 2025;246:108255.
    >> Share

  140. KOH MS, Xu X, Wei Lam SS, Wu JT, et al
    Public health insights of patients with asthma receiving primary, specialist or mixed care in Singapore using data from the SDG-CARE Asthma Registry.
    Respir Med. 2025 Jul 11:108252. doi: 10.1016/j.rmed.2025.108252.
    >> Share

  141. ACHTERBOSCH M, Hansen CME, Brand PLP, van Dijk L, et al
    Shared decision making and inhaled medication adherence in patients with COPD, asthma and cystic fibrosis: a systematic review.
    Respir Med. 2025 Jul 11:108251. doi: 10.1016/j.rmed.2025.108251.
    >> Share

  142. KISIEL MA, Zhou X, Fundberg I, Barrling A, et al
    Mortality and its predictive factors in participants with asthma: a 26-year follow-up.
    Respir Med. 2025;246:108253.
    >> Share

  143. BRAIDO F, Beeh KM, Serrano CC, Dinh-Xuan AT, et al
    Real-world use of beclometasone dipropionate and formoterol fumarate NEXThaler(R) and asthma control among adult asthmatic patients in Europe: The results of the NEWTON Study.
    Respir Med. 2025 Jul 9:108224. doi: 10.1016/j.rmed.2025.108224.
    >> Share

  144. DIEZ SIERRA J, Medina Gallardo JF, Munoz Sanchez B, Leon Lloreda A, et al
    FEV(1) Decline and Clinical Predictors in Asthma after 10 Years of Follow-Up: BMI as a Modifiable Risk Factor.
    Respir Med. 2025 Jul 4:108247. doi: 10.1016/j.rmed.2025.108247.
    >> Share

  145. AKSAMIT TR, Choate R, Mannino DM, Brunton AE, et al
    Natural history and burden of refractory Mycobacterium avium complex pulmonary disease: insights from the US Bronchiectasis and Nontuberculous Mycobacterial Research Registry.
    Respir Med. 2025 Jul 2:108220. doi: 10.1016/j.rmed.2025.108220.
    >> Share

  146. SHINGAI K, Ikeuchi T, Rassam P, Kozu R, et al
    Development of a new ambulatory oxygen delivery method combining continuous oxygen flow and demand oxygen delivery system: A prospective, single-blind, randomized crossover trial.
    Respir Med. 2025;243:108140.
    >> Share

  147. MAHAJAN AK, Collar N, Muldowney F, Ochoa Cuba MA, et al
    Incidence and outcomes for post-bronchoscopic lung volume reduction (BLVR) pneumothoraces stratified by target lobe treated.
    Respir Med. 2025;243:108148.
    >> Share

  148. ANYETEI-ANUM GP, White B, Yadav H, Kennedy CC, et al
    Effect of native lung disease on post-transplant best lung function.
    Respir Med. 2025;243:108128.
    >> Share

  149. MEKONNEN TC, Melaku YA, Shi Z, Gill TK, et al
    Joint analysis of diet quality, inflammatory potential of diet and ultra-processed food exposure in relation to chronic respiratory diseases and lung cancer mortality.
    Respir Med. 2025;243:108138.
    >> Share

  150. ROMERO-LINARES A, Alvarez-Muro L, Hammadi A, Hoyas-Sanchez C, et al
    Short term exacerbation risk and exhaled nitric oxide in COPD.
    Respir Med. 2025;243:108134.
    >> Share

  151. LOUGHRAN KJ, Trewartha G, Martin D, Fernandes-James C, et al
    Persistent pain is associated with poorer balance and gait performance for people with Chronic Obstructive Pulmonary Disease.
    Respir Med. 2025;243:108133.
    >> Share

  152. KLAPS S, Langer D, Gosselink R, Dacha S, et al
    The value of extra-diaphragmatic inspiratory muscle surface electromyography during postural control tasks in patients with chronic obstructive pulmonary disease.
    Respir Med. 2025;243:108127.
    >> Share

  153. HANSEN H, Godtfredsen N, Ulrik CS, Hansen J, et al
    Physical activity levels in Danish adults with and without asthma - A national recurrent cross-sectional case-control study from 2010 to 2021.
    Respir Med. 2025 Jul 1:108240. doi: 10.1016/j.rmed.2025.108240.
    >> Share

    June 2025
  154. ZHU W, Chen K, Xiang Y, Shi J, et al
    Real-World Respiratory Effectiveness of mepolizumab in Severe Eosinophilic Asthma and Eosinophilic Granulomatosis with Polyangiitis.
    Respir Med. 2025 Jun 26:108223. doi: 10.1016/j.rmed.2025.108223.
    >> Share

  155. ANTAO J, Rodrigues G, Deng Q, Baak BN, et al
    Trends in initial pharmacological treatment of asthma in primary care (2010-2021): A population-based study using the PHARMO data network.
    Respir Med. 2025;246:108222.
    >> Share

  156. ZHENG X, Jiang H, Cui R, Cai A, et al
    From Itchy Skin to Wheezing: Potential biomarkers and targeted drugs for Atopic Dermatitis and Asthma in Children.
    Respir Med. 2025 Jun 13:108212. doi: 10.1016/j.rmed.2025.108212.
    >> Share

  157. FREUND O, Hadad Y, Bergeron A, Fried S, et al
    Bronchiectasis after allogeneic hematopoietic cell transplantation - an underdiagnosed complication.
    Respir Med. 2025;245:108208.
    >> Share

  158. HANSEN S, Hakansson KEJ, Soendergaard MB, Bjerrum AS, et al
    Clinical response and remission in patients treated with dupilumab for severe asthma: Results from the nationwide Danish Severe Asthma Register.
    Respir Med. 2025 Jun 11:108203. doi: 10.1016/j.rmed.2025.108203.
    >> Share

  159. PINI L, Caminati M, Maule M, Bagnasco D, et al
    ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up.
    Respir Med. 2025;245:108198.
    >> Share

  160. BRAUNWALDER C, Ertl J, Wullschleger M, Timm E, et al
    Efficacy and safety of phytotherapy and anthroposophic medicine in bronchial asthma: A systematic review.
    Respir Med. 2025 Jun 7:108202. doi: 10.1016/j.rmed.2025.108202.
    >> Share

  161. TAY TR, Pang E, Liew MF, Tiew PY, et al
    Ethnic variation in South East Asian patients with Severe Asthma: A First Look at the Singapore Severe Asthma Registry (SSAR) and implications on clinical practice.
    Respir Med. 2025 Jun 5:108199. doi: 10.1016/j.rmed.2025.108199.
    >> Share

  162. COOPER DH, Akbarian N, Aaron SD, Luks V, et al
    Glucagon-like Peptide 1 (GLP-1) Receptor Agonists and Asthma and COPD Exacerbations in Adults with Diabetes: A Systematic Review.
    Respir Med. 2025 Jun 4:108197. doi: 10.1016/j.rmed.2025.108197.
    >> Share

  163. LI H, Huang X, Wei Z, Chen Z, et al
    Unveiling genetic links: GSDMB polymorphisms and asthma susceptibility in the Zhuang Nationality of Guangxi.
    Respir Med. 2025;245:108176.
    >> Share

  164. MATTA A, Polychronopoulou E, Kuo YF, Sharma G, et al
    Pulmonary rehabilitation utilization in patients with chronic respiratory diseases: 2014-2019.
    Respir Med. 2025;242:108110.
    >> Share

  165. LIGUORO I, Patui M, Vidoni M, Pilotto C, et al
    Comparison of the sensitivity and specificity of bronchiolitis severity scores in infants: a systematic review and meta-analysis.
    Respir Med. 2025;242:108111.
    >> Share

  166. BENFANTE A, Tomasello A, Pitruzzella A, Fucarino A, et al
    Exploring a novel approach to COPD treatment: benralizumab effect in an ex vivo 3-D model.
    Respir Med. 2025;242:108107.
    >> Share

  167. JALALVAND M, Tahermohammadi H, Madreseh E, Varahram M, et al
    Regulatory T cells in the blood of patients with chronic obstructive pulmonary disease (COPD): A systematic review and meta-analysis.
    Respir Med. 2025;242:108104.
    >> Share

  168. FANDOS VAZQUEZ P, Diez-Manglano J
    Thyroid hormones in people with chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Respir Med. 2025;242:108103.
    >> Share

  169. PIERRE C, Jeanne I, Mathieu B, Hugo G, et al
    Characteristics and risk factors of intubation in COPD patients with severe acute exacerbation: An exploratory single-center retrospective study.
    Respir Med. 2025;242:108095.
    >> Share

    May 2025
  170. HANANIA NA, Stanford R, Rendon A, Gemicioglu B, et al
    Comparative effectiveness of inhaled fluticasone propionate/salmeterol and budesonide/formoterol fixed-dose combinations in asthma control - a retrospective United States database analysis.
    Respir Med. 2025 May 28:108172. doi: 10.1016/j.rmed.2025.108172.
    >> Share

  171. ZHANG X, Zhang X, Wan Y, Xu D, et al
    The association between alpha-1-acid glycoprotein and asthma in United States: a cross-sectional study from NHANES.
    Respir Med. 2025;245:108174.
    >> Share

  172. ATALAY NA, Yormaz B, Sahin A, Sonmez G, et al
    Elevated HIF-1alpha as a Diagnostic Biomarker in COPD: Correlations with EPO, Emphysema Index, and Pulmonary Function.
    Respir Med. 2025 May 28:108184. doi: 10.1016/j.rmed.2025.108184.
    >> Share

  173. COTTINI M, Poto R, Bhattacharjee A, Galant S, et al
    Characterizing the preserved ratio impaired spirometry phenotype in all severities of asthma.
    Respir Med. 2025 May 27:108180. doi: 10.1016/j.rmed.2025.108180.
    >> Share

  174. DOUMAT G, Aksamit TR, Kanj AN
    Bronchiectasis: A clinical review of inflammation.
    Respir Med. 2025;244:108179.
    >> Share

  175. MOCHIZUKI F, Tanabe N, Iijima H, Shimada T, et al
    Prediction of airflow limitation in smokers using multiple CT imaging indices: airway wall thickness, quantitative emphysema, and visually identified centrilobular emphysema.
    Respir Med. 2025 May 20:108169. doi: 10.1016/j.rmed.2025.108169.
    >> Share

  176. XIANG J, Cui M
    Neutrophil Extracellular Traps and neutrophilic asthma.
    Respir Med. 2025 May 12:108150. doi: 10.1016/j.rmed.2025.108150.
    >> Share

  177. LEMACON C, Lopes AA
    Inhalers or nebulisation of salbutamol in childhood asthma exacerbations in emergency departments.
    Respir Med. 2025 May 8:108152. doi: 10.1016/j.rmed.2025.108152.
    >> Share

  178. MOERMANS C, Decerf N, Javaux N, Onssels A, et al
    High local type-2 inflammation is linked to response in severe asthma treated with anti-Interleukin-5 receptor.
    Respir Med. 2025 May 7:108151. doi: 10.1016/j.rmed.2025.108151.
    >> Share

  179. ZHONG Z, Zhang C, Zhao L, Zhao Y, et al
    Inhaled tobramycin in non-cystic fibrosis bronchiectasis: A meta-analysis of randomized controlled trials.
    Respir Med. 2025 May 6:108136. doi: 10.1016/j.rmed.2025.108136.
    >> Share

  180. WENNERGREN G, Lindberg A, Kauppi P, Kankaanranta H, et al
    Glimpses of diagnostic tools and treatment of asthma in Sweden, Norway, and Finland from a medico-historical perspective.
    Respir Med. 2025;243:108139.
    >> Share

  181. BULKHI AA, Elkkari A, Alghamdi BJ, Mahboub B, et al
    Defining Clinical Remission in Severe Asthma: Expert Opinion from the Gulf Region Using the Modified Delphi Method.
    Respir Med. 2025 May 3:108132. doi: 10.1016/j.rmed.2025.108132.
    >> Share

  182. OISHI K, Yasui H, Inoue Y, Hozumi H, et al
    The role of arterial stiffness as assessed by the cardio-ankle vascular index in patients with chronic obstructive pulmonary disease.
    Respir Med. 2025;241:108078.
    >> Share

  183. JIN C, Jin R, Liu D, Li Y, et al
    Genetically determined alpha-Klotho levels and causal association with aging-related lung diseases.
    Respir Med. 2025;241:108081.
    >> Share

  184. LU L, Wu F, Tang G, Wan Q, et al
    Associations of small airway dysfunction assessed by impulse oscillometry with lung function decline and exacerbations in participants with chronic obstructive pulmonary disease: A prospective cohort study in China.
    Respir Med. 2025;241:108075.
    >> Share

  185. ROBLES-HERNANDEZ RE, Montiel-Lopez F, Velazquez-Uncal M, Sansores RH, et al
    Efficacy of Indacaterol vs Tiotropium in COPD patients due to biomass exposure in improving quality of life and reducing symptoms.
    Respir Med. 2025;241:108074.
    >> Share

  186. ELIASON G, Ekstrom M, Montgomery S, Giezeman M, et al
    Associations of comorbid heart disease and depression/anxiety with multidimensional breathlessness in COPD - A cross-sectional study.
    Respir Med. 2025;241:108053.
    >> Share

  187. MALVI A, Khatib MN, Ganesan S, Kaur M, et al
    Assessing the impact of electronic nicotine delivery systems on chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Respir Med. 2025;241:108059.
    >> Share

  188. PISTENMAA CL, Hoffman EA, Prince MR, Hughes E, et al
    Platelet activation and COPD-related clinical and imaging characteristics: The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study.
    Respir Med. 2025;241:108058.
    >> Share

  189. MENDES MA, Janssen DJ, Marques A
    Palliative care education as an integrated component of pulmonary rehabilitation: A real-world mixed-methods feasibility study.
    Respir Med. 2025;241:108034.
    >> Share

  190. RO S, Aso S, Matsui H, Fushimi K, et al
    Association of once-daily single-device dual bronchodilators with prevention of rehospitalization for chronic obstructive pulmonary disease: A retrospective national inpatient database study.
    Respir Med. 2025;241:108033.
    >> Share

  191. VOGELMEIER CF, Rabe KF, Bhatt SP, Hanania NA, et al
    Dupilumab reduces acute exacerbations and improves lung function in patients with COPD with type 2 inflammation irrespective of body mass index, airflow obstruction, dyspnea, and exercise capacity index scores.
    Respir Med. 2025;241:108015.
    >> Share

    April 2025
  192. TSE SM, Babatounde AK, Drouin O, Radhakrishnan D, et al
    The association between the stringency of COVID-19 public health mitigation strategies and pediatric asthma-related hospitalizations in Canada: an ecological study over 2 years.
    Respir Med. 2025;243:108125.
    >> Share

  193. HUETHER KM, Lamb JM, Skelly J, Brigham E, et al
    Omega-3 Fatty Acid Intake Potentiates Bronchodilator Response in Patients with Obesity and Poorly Controlled Asthma.
    Respir Med. 2025 Apr 26:108131. doi: 10.1016/j.rmed.2025.108131.
    >> Share

  194. GHERASIM A, Dietsch F, Odul F, Riff T, et al
    Efficacy of air cleaners to reduce allergic responses to cat: a randomized clinical trial using an environmental exposure chamber.
    Respir Med. 2025 Apr 15:108105. doi: 10.1016/j.rmed.2025.108105.
    >> Share

  195. UNSAL H, Karaguzel D, Sarac BE, Aytekin ES, et al
    Inflammatory and oxidative stress markers in serum, urine and exhaled breath condensate: Relationship between asthma and obesity in children.
    Respir Med. 2025;242:108096.
    >> Share

  196. ERTAN YAZAR E, Karadag EH, Eren FA, Demirci B, et al
    Validation of probable COPD as proposed by the Lancet Commission at a smoking cessation clinic.
    Respir Med. 2025;239:108004.
    >> Share

  197. CHEN Z, Yue H, Gu Y, Xie C, et al
    Effect of traditional Chinese exercise on pulmonary function in middle-aged and older patients with stable chronic obstructive pulmonary disease: A randomized controlled trial.
    Respir Med. 2025;239:107997.
    >> Share

  198. SUN F, Ye M, Jumahan A, Aainiwaier A, et al
    MHR as a promising predictor for coronary artery disease in COPD patients: Insights from a retrospective nomogram study.
    Respir Med. 2025;239:107993.
    >> Share

  199. WARDYN PM, de Broucker V, Perez T, Demoulin-Alexikova S, et al
    Comparison of GLI-2021 standards with ECSC standards for static lung volume interpretation in patients with respiratory diseases.
    Respir Med. 2025;239:107988.
    >> Share

  200. SONG C, Hao X, Critselis E, Panagiotakos D, et al
    The impact of electronic cigarette use on chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Respir Med. 2025;239:107985.
    >> Share

  201. TAKIZAWA A, Shimada T, Chubachi S, Arai T, et al
    Exploring the pathophysiology of anemia in COPD: Insights from chest CT and longitudinal clinical data.
    Respir Med. 2025;240:108046.
    >> Share

  202. PIHLAJA H, Piili RP, Nuutinen M, Saarto T, et al
    The use of specialist palliative care services differs in chronic obstructive pulmonary disease and interstitial lung disease: A national cohort study.
    Respir Med. 2025;240:108045.
    >> Share

  203. DY ABC, Voraphani N, Spangenberg A, Belinsky SA, et al
    Circulating CC16, immune response to Mycoplasma pneumoniae and lung function: a population-based, multi-cohort study.
    Respir Med. 2025;240:108044.
    >> Share

  204. ZHANG S, Lin J
    Association of circadian syndrome and lung health: A population-based cohort study.
    Respir Med. 2025;240:108031.
    >> Share

  205. LIU Y, Huang J, Li E, Xiao Y, et al
    Analysis of research trends and hot spots on COPD biomarkers from the perspective of bibliometrics.
    Respir Med. 2025;240:108030.
    >> Share

  206. SATO H, Nagano T, Suraya R, Hazama D, et al
    Reduction in circulating Endothelin-1 levels by inhaled COPD medications.
    Respir Med. 2025;240:108027.
    >> Share

  207. SPITTLE DA, Pye A, Stanka J, De Soyza J, et al
    Bacterial colonisation doubles the risk of exacerbation in alpha-1 antitrypsin deficiency.
    Respir Med. 2025;240:108025.
    >> Share

  208. DAVOUDI DASTENAEI F, Belyani S, Esfahani AJ, Bahari H, et al
    Association of lifestyle components with prevalence of chronic obstructive pulmonary disease (COPD): Findings of a cohort study.
    Respir Med. 2025;240:108013.
    >> Share

  209. WEGLARZ K, Szczygiel E, Maslon A, Blaut J, et al
    Assessment of breathing patterns and voice of patients with COPD and dysphonia.
    Respir Med. 2025;240:108012.
    >> Share

  210. CANO A, Esteban C, Larrea N, Iriberri M, et al
    Factors associated with short- and medium-term mortality after hospitalization for COPD exacerbation.
    Respir Med. 2025;240:108010.
    >> Share

    March 2025
  211. STATEN T, Liu PH, Holt C, Alismail A, et al
    Effectiveness Of A Respiratory Therapist-Led, Community-Based Asthma Program In An Under resourced Rural Border Town In California.
    Respir Med. 2025 Mar 29:108071. doi: 10.1016/j.rmed.2025.108071.
    >> Share

  212. GREIG R, Chan R, Lipworth B
    Oscillometry and spirometry derived ratios to assess small airways dysfunction in severe asthma patients taking tezepelumab.
    Respir Med. 2025;241:108072.
    >> Share

  213. MENZELLA F, Cottini M, Lombardi C, Senna G, et al
    A Real-world Study on Tezepelumab Effectiveness in Severe Asthma Focusing on Small Airway Dysfunction.
    Respir Med. 2025 Mar 25:108054. doi: 10.1016/j.rmed.2025.108054.
    >> Share

  214. ECK S, Baumgartel A, Hapfelmeier A, Linde K, et al
    Effectiveness of an online asthma education program in adults with asthma in general practice: Results from a cluster randomised controlled trial.
    Respir Med. 2025;240:108041.
    >> Share

  215. GUINOSSI RM, Bertagni Mingotti CF, Burch MO, Teixeira Soares LA, et al
    Residential greenness, respiratory symptoms and lung function in children, adolescents and adults with asthma: a cross-sectional study.
    Respir Med. 2025 Mar 11:108038. doi: 10.1016/j.rmed.2025.108038.
    >> Share

  216. PELGROM AT, de Jongh IFHC, van den Aardweg JG, van Veen IHPAA, et al
    Analysis of the breathing pattern in patients with asthma during physical exercise: a cross-sectional study.
    Respir Med. 2025 Mar 11:108037. doi: 10.1016/j.rmed.2025.108037.
    >> Share

  217. ORTIZ J, Staggers KA, Adrish M, Hanania NA, et al
    Asthma outcomes in a safety net hospital system: A comparative study to a national cohort.
    Respir Med. 2025;240:108032.
    >> Share

  218. ZHAO C, Wang L, Zhang L, Wang Q, et al
    Asthma Exacerbation Comorbidity Index (AECI): Predicting In-Hospital Adverse Outcomes.
    Respir Med. 2025 Mar 3:108024. doi: 10.1016/j.rmed.2025.108024.
    >> Share

  219. GAO Q, Zhu H
    Investigating the risk factors for the coexistence of insomnia and its exacerbation in AECOPD.
    Respir Med. 2025;238:107987.
    >> Share

  220. OTTESEN TG, Rovsing AH, Ulrik CS
    Local and systemic adverse effects of inhaled corticosteroids - Does ciclesonide differ from other inhaled corticosteroids?
    Respir Med. 2025;238:107962.
    >> Share

  221. CHOUDHARY OA, Dhawan J, Sohrabipour S, Semenchuk J, et al
    Assessment of online YouTube videos as a source of information and instruction for pulmonary rehabilitation.
    Respir Med. 2025;238:107968.
    >> Share

  222. SOHRABIPOUR S, Ibrahim A, Dhawan J, Choudhary OA, et al
    Evaluation of online videos and websites on inspiratory muscle training for individuals with chronic lung disease.
    Respir Med. 2025;238:107967.
    >> Share

  223. SHI W, Li T, Leng Y, Li Q, et al
    Global prevalence of fatigue in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Respir Med. 2025;238:107969.
    >> Share

  224. CALZETTA L, Pistocchini E, Laitano R, Gholamalishahi S, et al
    Efficacy and safety of long-acting muscarinic antagonists in COPD: A meta-analysis and meta-regression with a focus on aging.
    Respir Med. 2025;238:107956.
    >> Share

    February 2025
  225. SUN C, Li N, Xiao X, Zhang Q, et al
    Association between lipid accumulation products and asthma among adults: Data from National Health and Nutrition Examination Survey (NHANES) 2003-2018.
    Respir Med. 2025;240:108017.
    >> Share

  226. TONE K
    Corrigendum to "Nodular-bronchiectatic pattern in pulmonary Nocardiosis: Immune status and treatment outcomes in a multicenter retrospective Study" [Respir. Med. 237 (2025) 107922].
    Respir Med. 2025 Feb 28:108009. doi: 10.1016/j.rmed.2025.108009.
    >> Share

  227. PORTACCI A, Iorillo I, Quaranta VN, Amendolara M, et al
    Diaphragm function in patients with asthma and healthy controls: a cross-sectional study.
    Respir Med. 2025 Feb 18:108008. doi: 10.1016/j.rmed.2025.108008.
    >> Share

  228. JIANG P, Lu H, Jiang Y, Li F, et al
    Association between the triglyceride-glucose index and mortality in the asthma population.
    Respir Med. 2025 Feb 8:107989. doi: 10.1016/j.rmed.2025.107989.
    >> Share

  229. CHIU SL, Chiang TI, Chen CL
    Identification and validation of SPP1 as a potential biomarker for COPD through comprehensive bioinformatics analysis.
    Respir Med. 2025;237:107953.
    >> Share

  230. GARCIA-MOGUEL I, Martinez-Mesa A, Andujar-Espinosa R, Diaz-Campos R, et al
    The impact of blood eosinophil count and FeNO on benralizumab effectiveness in clinical practice: An ORBE II subanalysis.
    Respir Med. 2025;237:107940.
    >> Share

  231. WANG D, Hua L, Bai W, Guo M, et al
    Peripheral blood immune cell dynamics associate with growth of incidental indeterminate pulmonary nodules.
    Respir Med. 2025;237:107947.
    >> Share

  232. MENDES LPS, Parreira VF, Rocha BC, Spencer LM, et al
    Glittre-ADL tests in three laps as an alternative to the five laps test.
    Respir Med. 2025;237:107945.
    >> Share

  233. ELMIGER A, Marcin T, Bovet L, Brun P, et al
    Pulmonary rehabilitation and functional independence: Impact on survival in patients with fibrotic interstitial lung disease or chronic obstructive pulmonary disease.
    Respir Med. 2025;237:107933.
    >> Share

  234. YANG Z, Zheng Y, Zhao J, Zhong Y, et al
    Impact of IL13 genetic polymorphisms on COPD susceptibility in the Chinese Han population.
    Respir Med. 2025;237:107923.
    >> Share

    January 2025
  235. TIOTIU A, Migueres N, Gonzalez-Barcala FJ, Roux P, et al
    Real-world comparison of T2-biologics effectiveness in severe allergic asthma with nasal polyps.
    Respir Med. 2025;238:107979.
    >> Share

  236. OKAY B, Hatipoglu HU, Okay ZU, Sahin K, et al
    COMPARING MESH AND COMPRESSOR NEBULIZERS IN PULMONARY FUNCTION TEST IN PEDIATRIC ASTHMA ATTACKS: A DOUBLE-BLIND RANDOMIZED COMPARATIVE CLINICAL TRIAL.
    Respir Med. 2025 Jan 28:107966. doi: 10.1016/j.rmed.2025.107966.
    >> Share

  237. CAZZOLA M, Calzetta L, Matera MG, Rogliani P, et al
    Challenges in treating patients with comorbid asthma and bronchiectasis.
    Respir Med. 2025 Jan 21:107957. doi: 10.1016/j.rmed.2025.107957.
    >> Share

  238. COSINI FF, Bagnasco D, Braido F, Canonica GW, et al
    Background therapy in severe asthma on monoclonal antibody treatment in real life.
    Respir Med. 2025;237:107944.
    >> Share

  239. HORVATH A, Farkas A, Reti I, Ilyes N, et al
    Particularities of deposition of two ICS-LABA fixed dose combination dry powder aerosol drugs in the airways of COPD patients.
    Respir Med. 2025;236:107916.
    >> Share

  240. XU H, Jiang X, Zeng Q, Li R, et al
    Application of e-Health tools in the assessment of inhalation therapy adherence in patients with chronic obstructive pulmonary disease: Scoping review coupled with bibliometric analysis.
    Respir Med. 2025;236:107898.
    >> Share

  241. KRIMSKY WS, VanderLaan PA, Iding JS, Hunter DW, et al
    A quantitative method for assessing treatment-related changes within the airway mucosa in patients with chronic bronchitis.
    Respir Med. 2025;236:107889.
    >> Share

  242. DELBRESSINE JM, Vaes AW, Stoop WAM, Van Ranst D, et al
    Reproducibility of three 6-min walk tests in patients with COPD referred for pulmonary rehabilitation.
    Respir Med. 2025;236:107884.
    >> Share

  243. YAPPALPARVI A, Balaraman AK, Padmapriya G, Gaidhane S, et al
    Safety and efficacy of ensifentrine in COPD: A systemic review and meta-analysis.
    Respir Med. 2025;236:107863.
    >> Share

    December 2024
  244. HASEGAWA A, Tone K, Baba Y, Saito Z, et al
    Nodular-bronchiectatic Pattern in Pulmonary Nocardiosis: Immune Status and Treatment Outcomes in a Multicenter Retrospective Study.
    Respir Med. 2024 Dec 23:107922. doi: 10.1016/j.rmed.2024.107922.
    >> Share

  245. BELHASSEN M, Marchal C, Deygas F, Jacoud F, et al
    In patients with asthma, obesity status is associated with poor control and high exacerbation rates, which are reversed after bariatric surgery.
    Respir Med. 2024;236:107917.
    >> Share

  246. AJAZ M, Singh I, Vugic L, Jani R, et al
    The interplay of plant-based antioxidants, inflammation, and clinical outcomes in asthma: A systematic review.
    Respir Med. 2024;236:107918.
    >> Share

  247. ALFAHL Z, Einarsson GG, Elborn JS, Gilpin DF, et al
    Airway total bacterial density, microbiota community composition and relationship with clinical parameters in bronchiectasis.
    Respir Med. 2024;236:107906.
    >> Share

  248. DONOHUE P, Connolly M, D'Alfonso M, Jackson G, et al
    Peripheral Airways Dysfunction Measured by Oscillometry Differentiates Asthma from Inducible Laryngeal Obstruction.
    Respir Med. 2024 Dec 2:107905. doi: 10.1016/j.rmed.2024.107905.
    >> Share

  249. PETAT H, Marguet C
    Three-year outcome of a very young severe uncontrolled preschool wheezers cohort, a real-life study.
    Respir Med. 2024;235:107875.
    >> Share

  250. SCIOSCIA G, Baraldi F, Bigoni T, Papi A, et al
    The precision medicine strategy to treat COPD pulmonary traits in clinical practice: The role of N-acetylcysteine.
    Respir Med. 2024;235:107865.
    >> Share

    November 2024
  251. GEMICIOGLU B, Gokmen D, Can A, Sevinc C, et al
    Factors Influencing the Prescription of Add-on Long-Acting Muscarinic Antagonists in Real-World Asthma Management: Insights from a National Registry.
    Respir Med. 2024 Nov 29:107883. doi: 10.1016/j.rmed.2024.107883.
    >> Share

  252. FARSHID S, Buckland BC, Shanmuganathan S, Low GK, et al
    End-tidal carbon dioxide, a point-of-care biomarker to assess severity in acute asthma: A systematic review.
    Respir Med. 2024 Nov 29:107891. doi: 10.1016/j.rmed.2024.107891.
    >> Share

  253. YASUI H, Oishi K, Nihashi F, Furuhashi K, et al
    Factors associated with uncontrolled severe asthma in the biologic era.
    Respir Med. 2024;236:107881.
    >> Share

  254. ERRASTI VIADER J, Martinez Gonzalez MA, Campo Ezquibela A, Bes-Rastrollo M, et al
    Dietary patterns and asthma incidence in adult population. Systematic review and meta-analysis.
    Respir Med. 2024 Nov 19:107861. doi: 10.1016/j.rmed.2024.107861.
    >> Share

  255. GANGEMI AJ, Dass CA, Zhao H, Patel M, et al
    Advanced Emphysema Leads to High False Positivity Rate for Pneumothorax in Point of Care Ultrasound.
    Respir Med. 2024 Nov 16:107860. doi: 10.1016/j.rmed.2024.107860.
    >> Share

  256. SESHADRI N, Faig W, Young LR, Hill DA, et al
    Risk Factors for Hospitalization in Subspecialty Patients with Severe Persistent Asthma.
    Respir Med. 2024 Nov 15:107867. doi: 10.1016/j.rmed.2024.107867.
    >> Share

  257. GOMEZ LF, Kinnee E, Kaufman JD, Young MT, et al
    Modification of asthma treatment efficacy by healthcare access: A reanalysis of AsthmaNet Step-Up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations (STICS) clinical trial.
    Respir Med. 2024;234:107853.
    >> Share

  258. HUG S, Cavalheri V, Hill K, Gucciardi DF, et al
    Road to referral success in COPD: Enhancing patient engagement through dedicated conversations about pulmonary rehabilitation programs.
    Respir Med. 2024;233:107790.
    >> Share

  259. LI C, Lian X, He J, Gao X, et al
    Association of computed tomography-derived pectoralis muscle area and density with disease severity and respiratory symptoms in patients with chronic obstructive pulmonary disease: A case-control study.
    Respir Med. 2024;233:107783.
    >> Share

  260. GRASL MT, Agusti A, Azizzadeh M, Karimi A, et al
    Prevalence and etiotypes of persistent airflow obstruction in the general population across the lifetime.
    Respir Med. 2024;233:107779.
    >> Share

  261. HAMADA R, Tanabe N, Oshima Y, Yoshioka Y, et al
    Phase angle measured by bioelectrical impedance analysis in patients with chronic obstructive pulmonary disease: Associations with physical inactivity and frailty.
    Respir Med. 2024;233:107778.
    >> Share

  262. HANSEN KK, Hilberg O, Lokke A
    High prevalence of undiagnosed and treatment-requiring obstructive sleep apnea and nocturnal desaturation in outpatients with severe chronic obstructive pulmonary disease.
    Respir Med. 2024;233:107771.
    >> Share

  263. ALQAHTANI JS, Arowosegbe A, Aldhahir AM, Alghamdi SM, et al
    Prevalence and burden of loneliness in COPD: A systematic review and meta-analysis.
    Respir Med. 2024;233:107768.
    >> Share

  264. IGNACIO CARLOTTO C, Bernardes S, Zanella P, Silva FM, et al
    Dietary patterns and risk of Chronic Obstructive Pulmonary Disease (COPD) and clinical outcomes in diagnosed patients: A scoping review.
    Respir Med. 2024;233:107773.
    >> Share

  265. BAKKER JT, Hartman JE, Klooster K, Charbonnier JP, et al
    Endobronchial valve treatment improves chest-CT diaphragm configuration in COPD.
    Respir Med. 2024;234:107856.
    >> Share

  266. BOERSMA R, Bakker JT, de Vries M, Raveling T, et al
    Defining a phenotype of severe COPD patients who develop chronic hypercapnia.
    Respir Med. 2024;234:107850.
    >> Share

  267. BUCHARDT STE, Weinreich UM, Lindgren FL, Lauridsen MD, et al
    Patient characteristics and mortality across diagnostic settings in COPD.
    Respir Med. 2024;234:107843.
    >> Share

  268. SAADI R, Rangwala R, Shaikh H, Laghi F, et al
    The effects of noninvasive respiratory support on swallowing physiology, airway protection, and respiratory-swallow pattern in adults: A systematic review.
    Respir Med. 2024;234:107844.
    >> Share

  269. PHANTAYUTH D, Chuaychoo B, Supaporn S, Nana A, et al
    Effectiveness of a 12-week combining tai chi and yoga program on pulmonary function and functional fitness in COPD patients.
    Respir Med. 2024;234:107842.
    >> Share

  270. HOU XF, Hou CG
    Association between acute tobacco exposure and fractional exhaled nitric oxide in patients with chronic obstructive pulmonary disease: National health and Nutrition Examination Survey (NHANES) 2007-2012.
    Respir Med. 2024;234:107831.
    >> Share

  271. CHOATE R, Holm KE, Sandhaus RA, Mannino DM, et al
    Physical and mental health trajectories: A longitudinal SF-36 analysis in Alpha-1 antitrypsin deficiency-associated COPD.
    Respir Med. 2024;234:107838.
    >> Share

  272. TOFOLI TM, Santin L, Medeiros L, Silva H, et al
    Determinant factors of sedentary time in individuals with COPD.
    Respir Med. 2024;234:107839.
    >> Share

  273. TAN DJ, Finlay P, Siu H, Fan IM, et al
    Impaired diffusing capacity and COPD incidence in adults with symptoms and normal spirometry.
    Respir Med. 2024;234:107832.
    >> Share

  274. COX NS, Barton C, Bondarenko J, Clark R, et al
    Characterizing pulmonary rehabilitation referrals from primary care.
    Respir Med. 2024;234:107822.
    >> Share

  275. SHANMUGAVEL GEETHA H, Teo YX, Ravichandran S, Perkit NR, et al
    Use of Sodium-glucose cotransporter 2 (SGLT 2) inhibitor is associated with reduced emergency room visits and hospitalizations in patients with Chronic obstructive pulmonary disease (COPD) and type 2 Diabetes Mellitus.
    Respir Med. 2024;234:107819.
    >> Share

  276. ZHU Z
    Advancements in automated classification of chronic obstructive pulmonary disease based on computed tomography imaging features through deep learning approaches.
    Respir Med. 2024;234:107809.
    >> Share

  277. SHI Q, Xu J, Zeng L, Lu Z, et al
    A nomogram for predicting short-term mortality in ICU patients with coexisting chronic obstructive pulmonary disease and congestive heart failure.
    Respir Med. 2024;234:107803.
    >> Share

  278. JANG JG, Kim Y, Shin SH, Min KH, et al
    The role of FEV(1)/FVC in the prediction of acute exacerbation of COPD.
    Respir Med. 2024;234:107780.
    >> Share

    October 2024
  279. BHATT SP, Rabe KF, Hanania NA, Vogelmeier CF, et al
    Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS).
    Respir Med. 2024 Oct 29:107846. doi: 10.1016/j.rmed.2024.107846.
    >> Share

  280. CAZZOLA M, Ora J, Calzetta L, Rogliani P, et al
    beta-Blockers and Asthma: Surprising Findings from the FAERS Database.
    Respir Med. 2024 Oct 26:107849. doi: 10.1016/j.rmed.2024.107849.
    >> Share

  281. BOURBEAU J
    In COPD- right treatment, right patient, right time, right approach?
    Respir Med. 2024;232:107769.
    >> Share

  282. PANTAZOPOULOS I, Boutlas S, Mavrovounis G, Papalampidou A, et al
    Nasal high flow or noninvasive ventilation? navigating hypercapnic COPD exacerbation treatment: A randomized noninferiority clinical trial.
    Respir Med. 2024;232:107762.
    >> Share

  283. LAURIDSEN MD, Grontved S, Fosbol E, Johnsen SP, et al
    Treatment intensity level as a proxy for severity of chronic obstructive pulmonary disease: A risk stratification tool.
    Respir Med. 2024;232:107742.
    >> Share

  284. ZHENG K, Tang L, Wang X, Chen L, et al
    The risk factors for chronic cough in children: A meta-analysis covering five continents.
    Respir Med. 2024;232:107752.
    >> Share

  285. WU W, Guan L, Guo B, Yang Y, et al
    Respiratory physiological mechanism of two types of equal-intensity inspiratory muscle training in stable patients with chronic obstructive pulmonary disease.
    Respir Med. 2024;232:107747.
    >> Share

  286. WU WW
    Association of naples prognostic score and lung health: A population-based study.
    Respir Med. 2024;232:107751.
    >> Share

  287. DELACOSTE FBC, Goulart CDL, Guidoti AB, Turck P, et al
    Evaluating the impact of short-term nitrate-rich dietary supplementation on endothelial function in COPD: A randomized crossover study.
    Respir Med. 2024;232:107745.
    >> Share

  288. MUNOZ MONTIEL A, Ruiz-Esteban P, Domenech Del Rio A, Valdivielso P, et al
    The effect of pulmonary rehabilitation on cardiovascular risk, oxidative stress and systemic inflammation in patients with COPD.
    Respir Med. 2024;232:107740.
    >> Share

    September 2024
  289. HAMELMANN E, Csonka P, Roberts G, Vogelberg C, et al
    High burden of respiratory allergy in children warrants early identification and treatment with allergen immunotherapy.
    Respir Med. 2024 Sep 24:107812. doi: 10.1016/j.rmed.2024.107812.
    >> Share

  290. HAKANSSON KEJ, Alabdulkarim N, Guerrero SC, Backer V, et al
    Real-world phenotyping and risk assessment of childhood asthma burden using national registries.
    Respir Med. 2024;234:107808.
    >> Share

  291. NOPSOPON T, Brown A, Hahn G, Rank M, et al
    Temporal variation in the effectiveness of biologics in asthma: Effect modification by changing patient characteristics.
    Respir Med. 2024 Sep 9:107802. doi: 10.1016/j.rmed.2024.107802.
    >> Share

  292. FAT M, Andersen T, Fazio JC, Park SC, et al
    Association of bronchial disease on CT imaging and clinical definitions of chronic bronchitis in a single-center COPD phenotyping study.
    Respir Med. 2024;231:107733.
    >> Share

  293. BISHOP JA, Spencer LM, Dwyer TJ, McKeough ZJ, et al
    Patterns of physical activity of people with COPD during participation in a pulmonary rehabilitation program.
    Respir Med. 2024;231:107724.
    >> Share

  294. SCHAFAUSER NS, Sampaio LMM, Heubel AD, Kabbach EZ, et al
    Influence of heart failure (HF) comorbidity in chronic obstructive pulmonary disease (COPD) and isolated forms of HF and COPD on cardiovascular function during hospitalization.
    Respir Med. 2024;231:107731.
    >> Share

  295. WSHAH A, Alqatarneh N, Al-Nassan S, Goldstein R, et al
    Factors related to the implementation of pulmonary rehabilitation in Jordan: Perspective of healthcare professionals.
    Respir Med. 2024;231:107728.
    >> Share

  296. GUO L, Bilimoria SN, Kikuchi R, Hao A, et al
    Prevalence, incidence, and risk of chronic obstructive pulmonary disease among psoriasis patients.
    Respir Med. 2024;231:107729.
    >> Share

  297. SMIRNOVA N, Cross SH, Light A, Kavalieratos D, et al
    Racial differences in palliative care and hospice among adults with chronic obstructive pulmonary disease.
    Respir Med. 2024;231:107719.
    >> Share

  298. QUEZADA WA, Angulo D, Murray S, Joo M, et al
    Exacerbation-like events in the 12 months prior to identification of chronic respiratory conditions in a primary care population.
    Respir Med. 2024;231:107695.
    >> Share

  299. RISEBROUGH NA, Mursleen S, Ndirangu K, Shah D, et al
    The long-term clinical and economic benefits of treating advanced COPD patients with single-inhaler triple therapy in Quebec, Canada - The IMPACT trial.
    Respir Med. 2024;231:107694.
    >> Share

    August 2024
  300. WHARTON R, Mathis N, Wang JG, Meislin R, et al
    Feasibility of Remote Spirometry Monitoring of Asthma in Pregnancy.
    Respir Med. 2024 Aug 24:107782. doi: 10.1016/j.rmed.2024.107782.
    >> Share

  301. WEBB EM, Holland AE, Chang AB, Burr L, et al
    Current physiotherapy practice for adults with bronchiectasis: Data from the Australian bronchiectasis registry.
    Respir Med. 2024;233:107777.
    >> Share

  302. TERL M, Diamant Z, Kosturiak R, Jesenak M, et al
    Choosing the right biologic treatment for individual patients with severe asthma - lessons learnt from Picasso.
    Respir Med. 2024 Aug 22:107766. doi: 10.1016/j.rmed.2024.107766.
    >> Share

  303. NORWEG A, Oh C, Nolan A
    Onion Consumption is Protective Against Asthma Risk in Children: ROAD to Health Population-based Cohort Study.
    Respir Med. 2024 Aug 11:107767. doi: 10.1016/j.rmed.2024.107767.
    >> Share

  304. DITTRICH AS, Kontogianni K, Unterschemmann AS, De Rossi S, et al
    Efficacy and safety of simultaneous combined Zephyr and Spiration valve therapy in patients with advanced pulmonary emphysema.
    Respir Med. 2024 Aug 2:107760. doi: 10.1016/j.rmed.2024.107760.
    >> Share

  305. KIZMAZ E, Telli Atalay O, Cetin N, Ugurlu E, et al
    Virtual reality for COPD exacerbation: A randomized controlled trial.
    Respir Med. 2024;230:107696.
    >> Share

  306. KARJALAINEN J, Vartiainen V, Tikkakoski A, Malmberg LP, et al
    Salbutamol Easyhaler provides non-inferior relief of methacholine induced bronchoconstriction in comparison to Ventoline Evohaler with spacer: A randomized trial.
    Respir Med. 2024;230:107693.
    >> Share

  307. NGUYEN KT, Brooks D, Macedo LG, Ellerton C, et al
    Balance measures for fall risk screening in community-dwelling older adults with COPD: A longitudinal analysis.
    Respir Med. 2024;230:107681.
    >> Share

  308. JOO H, Yoon HK, Hwang YI, Kim SH, et al
    Application of the Lancet Commission COPD classification to COPD Cohort Population in South Korea.
    Respir Med. 2024;230:107679.
    >> Share

    July 2024
  309. BULT L, Thelen JC, Rauh SP, Veen JCCMI', et al
    Dupilumab responder types and predicting factors in patients with type 2 severe asthma: a real-world cohort study.
    Respir Med. 2024 Jul 9:107720. doi: 10.1016/j.rmed.2024.107720.
    >> Share

  310. LOCCI C, Puci MV, Saderi L, Sotgiu G, et al
    The complex link between sleep-disordered breathing and asthma control in pediatric patients: a cross-sectional study.
    Respir Med. 2024 Jul 2:107730. doi: 10.1016/j.rmed.2024.107730.
    >> Share

  311. SORIANO JB, Polverino F
    Sexual activity and respiratory disease: A systematic review.
    Respir Med. 2024;228:107665.
    >> Share

  312. LIAO KM, Chiu CC, Lu HY
    The risk of secondary spontaneous pneumothorax in patients with chronic obstructive pulmonary disease in Taiwan.
    Respir Med. 2024;228:107672.
    >> Share

  313. LI L, Wang L, Zhang L, Zhao C, et al
    Frailty and in-hospital mortality in older patients with acute exacerbation of COPD: A real-world prospective cohort study.
    Respir Med. 2024;228:107663.
    >> Share

  314. YOUNES A, Mandigout S, Robin L, Borel B, et al
    What kind of non-pharmacological strategy for reducing sedentary behavior in COPD? Data from a scoping review.
    Respir Med. 2024;228:107662.
    >> Share

    June 2024
  315. VISSER CD, Faay MRA, Ozdemir A, Guchelaar HJ, et al
    Short-acting beta(2)-agonists (SABA) overuse in asthma and patients' perceptions for this behavior.
    Respir Med. 2024 Jun 25:107723. doi: 10.1016/j.rmed.2024.107723.
    >> Share

  316. PACKHAM S, Odling M, Bossios A, Konradsen JR, et al
    Adherence to inhaled corticosteroid therapy and treatment escalation in the Swedish adult asthma population.
    Respir Med. 2024;231:107714.
    >> Share

  317. HE ZF, Lin SZ, Pan CX, Chen ZM, et al
    The roles of bacteria and viruses in COPD-Bronchiectasis association: A prospective cohort study.
    Respir Med. 2024 Jun 7:107692. doi: 10.1016/j.rmed.2024.107692.
    >> Share

  318. MARTINEZ-GONZALEZ CL, Camargo Fajardo MCC, Martinez-Ortiz EJ, Segura Medina P, et al
    A soft systems approach of asthma management in children based on therapeutic education and e-learning.
    Respir Med. 2024 Jun 4:107691. doi: 10.1016/j.rmed.2024.107691.
    >> Share

  319. ISLAM N, Reid D
    Inhaled antibiotics: A promising drug delivery strategies for efficient treatment of lower respiratory tract infections (LRTIs) associated with antibiotic resistant biofilm-dwelling and intracellular bacterial pathogens.
    Respir Med. 2024;227:107661.
    >> Share

  320. RAZJOUYAN J, Hanania NA, Nowakowski S, Agrawal R, et al
    Identification of sleep phenotypes in COPD using machine learning-based cluster analysis.
    Respir Med. 2024;227:107641.
    >> Share

  321. CHOUDHURY P, Dasgupta S, Kar A, Sarkar S, et al
    Bioinformatics analysis of hypoxia associated genes and inflammatory cytokine profiling in COPD-PH.
    Respir Med. 2024;227:107658.
    >> Share

  322. KOSTER TD, Shah PL, Valipour A, Criner GJ, et al
    Optimizing clinical outcomes for bronchoscopic lung volume reduction with Zephyr(R) valves.
    Respir Med. 2024;227:107639.
    >> Share

  323. GOMES VMR, Pires MC, Delfino Pereira P, Schwarzbold AV, et al
    AB(2)CO risk score for in-hospital mortality of COVID-19 patients admitted to intensive care units.
    Respir Med. 2024;227:107635.
    >> Share

  324. ZELL-BARAN LM, Krefft SD, Strand M, Rose CS, et al
    Longitudinal changes in lung function following post-9/11 military deployment in symptomatic veterans.
    Respir Med. 2024;227:107638.
    >> Share

  325. YOHANNES AM, Casaburi R, Dryden S, Hanania NA, et al
    Sex differences and determinants of anxiety symptoms in patients with COPD initiating pulmonary rehabilitation.
    Respir Med. 2024;227:107633.
    >> Share

  326. LAPI F, Marconi E, Lombardo FP, Cricelli I, et al
    Development and validation of a prediction score to assess the risk of incurring in COPD-related exacerbations: a population-based study in primary care.
    Respir Med. 2024;227:107634.
    >> Share

    May 2024
  327. LO CASTO M, Marino S, Zammuto MM, Tomasello A, et al
    Patients with bronchiectasis have a lower combined risk of cardiovascular risk factors and cardiovascular comorbidity compared to patients with COPD.
    Respir Med. 2024;229:107683.
    >> Share

  328. AL-AHMAD M, Al Zaabi A, Madkour A, Alqaraghuli HA, et al
    Expert Consensus on Oral Corticosteroids Stewardship for the Treatment of Severe Asthma in the Middle East and Africa.
    Respir Med. 2024 May 21:107674. doi: 10.1016/j.rmed.2024.107674.
    >> Share

  329. AKSAMIT TR, Lapinel NC, Choate R, Feliciano J, et al
    Association between bronchiectasis exacerbations and longitudinal changes in FEV(1) in patients from the US Bronchiectasis and NTM Research Registry.
    Respir Med. 2024 May 9:107660. doi: 10.1016/j.rmed.2024.107660.
    >> Share

  330. ZHOU Y, Duan S, Zhang L, Peng F, et al
    Cost-effectiveness analysis of fluticasone furoate/umeclidinium bromide/vilanterol and umeclidinium bromide/vilanterol in the management of moderate and severe COPD in China.
    Respir Med. 2024;226:107632.
    >> Share

  331. BETANCOR D, Barroso B, Valverde-Monge M, Gomez-Lopez A, et al
    The discrepancy in bronchodilator response between ATS/ERS 2021 and 1991 criteria.
    Respir Med. 2024;226:107609.
    >> Share

  332. STOUSTRUP AL, Janssen DJA, Nakken N, Wouters EFM, et al
    Association of inadequate social support and clinical outcomes in patients with chronic obstructive pulmonary disease - A cross-sectional study.
    Respir Med. 2024;226:107625.
    >> Share

  333. LUNDELL S, Isaksson U, Coe AB, Harrison SL, et al
    Swedish translation and psychometric testing of the Self-Conscious Emotions in COPD Questionnaire.
    Respir Med. 2024;226:107624.
    >> Share

  334. LUU B, Chinnadurai A, Choudhary O, Breede N, et al
    A comprehensive evaluation of online inhaler use techniques for obstructive airway disease.
    Respir Med. 2024;226:107607.
    >> Share

  335. ZYSMAN M, Coquelin A, Le Guen N, Solomiac A, et al
    Prevalence and disparities in influenza vaccination among patients with COPD: A French nationwide population study.
    Respir Med. 2024;226:107606.
    >> Share

    April 2024
  336. GOTO T, Hernandez CG, Tsujimoto Y, Kitagawa T, et al
    Are biologics effective on lung hyperinflation in patients with resistant asthma?
    Respir Med. 2024 Apr 30:107652. doi: 10.1016/j.rmed.2024.107652.
    >> Share

  337. CAZZOLA M, Maniscalco M
    Are biologics effective on lung hyperinflation in patients with resistant asthma? A reply.
    Respir Med. 2024 Apr 26:107653. doi: 10.1016/j.rmed.2024.107653.
    >> Share

  338. JI H, Tan LD, Hafzella G, Nguyen N, et al
    Navigating Biologic Therapies in Elderly Asthma.
    Respir Med. 2024 Apr 26:107655. doi: 10.1016/j.rmed.2024.107655.
    >> Share

  339. CANONICA GW, Domingo C, Lavoie KL, Kaliasethi A, et al
    Asthma patients' and physicians' perspectives on the burden and management of asthma: post-hoc analysis of APPaRENT 1 and 2 to assess predictors of treatment adherence.
    Respir Med. 2024 Apr 16:107637. doi: 10.1016/j.rmed.2024.107637.
    >> Share

  340. ROBERTS MH, Duh MS, Rothnie KJ, Zhang S, et al
    Development and validation of a claims-based algorithm to identify moderate exacerbations in patients with asthma treated in the US.
    Respir Med. 2024 Apr 7:107630. doi: 10.1016/j.rmed.2024.107630.
    >> Share

  341. SHENG DUH M, Roberts MH, Rothnie KJ, Cheng WY, et al
    Frequency and economic burden of exacerbations in inhaled corticosteroid/long-acting beta-agonist-treated patients with asthma: a retrospective US claims study.
    Respir Med. 2024 Apr 7:107629. doi: 10.1016/j.rmed.2024.107629.
    >> Share

  342. FARKAS A, Horvath A, Reti I, Ilyes N, et al
    Comparative study of the inhalation parameters of COPD patients through NEXThaler(R) and Ellipta(R) dry powder inhalers.
    Respir Med. 2024;224:107576.
    >> Share

  343. MONDAL P, Lopez SP, Khokhar A, Snyder D, et al
    The influence of body mass index on airway resistance in children with sickle cell disease: A longitudinal study based on impulse oscillometry.
    Respir Med. 2024;224:107564.
    >> Share

  344. MAROTT JL, Ingebrigtsen TS, Colak Y, Vestbo J, et al
    Predicting exacerbations in COPD in the Danish general population.
    Respir Med. 2024;224:107557.
    >> Share

  345. BROCKWAY K, Ahmed S
    Beyond breathing: Systematic review of global chronic obstructive pulmonary disease guidelines for pain management.
    Respir Med. 2024;224:107553.
    >> Share

  346. LAI K, Sun D, Dai R, Samoro R, et al
    Benralizumab efficacy and safety in severe asthma: A randomized trial in Asia.
    Respir Med. 2024 Apr 1:107611. doi: 10.1016/j.rmed.2024.107611.
    >> Share

  347. GOTO T, Banno M, Kimura R
    Revisiting the use of high flow nasal cannula in acute exacerbation of COPD and conclusion of trial.
    Respir Med. 2024;225:107602.
    >> Share

  348. LORENZANA I, Galera R, Casitas R, Martinez-Ceron E, et al
    Dynamic hyperinflation is a risk factor for mortality and severe exacerbations in COPD patients.
    Respir Med. 2024;225:107597.
    >> Share

  349. XU X, Yin J, Yang Y, Liu H, et al
    Advances in co-pathogenesis of the united airway diseases.
    Respir Med. 2024;225:107580.
    >> Share

  350. STEGER M, Canuet M, Enache I, Goetsch T, et al
    Survival and response to pulmonary vasodilator therapies in patients with chronic obstructive pulmonary disease and pulmonary vascular phenotype.
    Respir Med. 2024;225:107585.
    >> Share

  351. BELL K, Lawson J, Penz E, Cammer A, et al
    Systematic review of tailored dietary advice and dietitian involvement in the treatment of chronic obstructive pulmonary disease (COPD).
    Respir Med. 2024;225:107584.
    >> Share

  352. VERWEEL L, Packham T, Goldstein R, Brooks D, et al
    Implementation of virtual pulmonary rehabilitation during the COVID-19 pandemic: Experiences and perceptions of patients and healthcare providers.
    Respir Med. 2024;225:107588.
    >> Share

  353. LUO L, Tang J, Du X, Li N, et al
    Chronic obstructive pulmonary disease and the airway microbiome: A review for clinicians.
    Respir Med. 2024;225:107586.
    >> Share

    March 2024
  354. YORGANCIOGLU A, Cruz AA, Garcia G, Lavoie KL, et al
    A network meta-analysis of the association between patient traits and response to regular dosing with ICS plus short-acting beta(2)-agonist reliever or ICS/formoterol reliever only in mild asthma.
    Respir Med. 2024 Mar 30:107610. doi: 10.1016/j.rmed.2024.107610.
    >> Share

  355. JEONG J, Nam YH, Sim DW, Kim BK, et al
    Relationship of computed tomography-based measurements with symptom perception and quality of life in patients with severe asthma.
    Respir Med. 2024;225:107598.
    >> Share

  356. WIJSMAN PC, Goorsenberg AWM, d'Hooghe JNS, Weersink EJM, et al
    Exhaled breath analyses for bronchial thermoplasty in severe asthma patients.
    Respir Med. 2024 Mar 4:107583. doi: 10.1016/j.rmed.2024.107583.
    >> Share

  357. NIERI D, Morani C, De Francesco M, Gaeta R, et al
    Enhanced prothrombotic and proinflammatory activity of circulating extracellular vesicles in acute exacerbations of chronic obstructive pulmonary disease.
    Respir Med. 2024;223:107563.
    >> Share

  358. LAI Y, Cavalheri V, Sawyer A, Hill K, et al
    Exercise training initiated early during hospitalisation in individuals with chronic obstructive pulmonary disease is safe and improves exercise capacity and physical function at hospital discharge: A systematic review and meta-analysis.
    Respir Med. 2024;223:107554.
    >> Share

  359. LAU F, Schupp T, Schmitt A, Reinhardt M, et al
    Prognostic impact of chronic obstructive pulmonary disease in patients with heart failure with mildly reduced ejection fraction.
    Respir Med. 2024;223:107536.
    >> Share

    February 2024
  360. MANISCALCO M, Candia C, Calabrese C, D'Amato M, et al
    Impact of biologics on lung hyperinflation in patients with severe asthma.
    Respir Med. 2024 Feb 29:107578. doi: 10.1016/j.rmed.2024.107578.
    >> Share

  361. ALMQVIST L, Andersson M, Backman H, Ronmark E, et al
    No remission in 60% of those with childhood-onset asthma - A population-based cohort followed from 8 to 28 years of age.
    Respir Med. 2024 Feb 26:107581. doi: 10.1016/j.rmed.2024.107581.
    >> Share

    November 2023
  362. LAVORINI F, Usmani OS, Salvi S, Rote K, et al
    A narrative review on the Synchrobreathe: A novel breath-actuated pressurised metered-dose inhaler for the treatment of obstructive airway diseases.
    Respir Med. 2023;219:107435.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016